Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06832878 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty

StatusRecruiting
PhasePhase 4
Started2026-06-01
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Jun 2026 → Jun 2027
See other at-risk trials from Mayo Clinic

Amendment history

2026-08-07
critical
Study Status, Contacts/Locations v5
Recruitment opened
Primary completion pushed: 2026-06 → 2027-06
Completion pushed: 2026-06 → 2027-06
Study sitesdetails revised at 1 of 1 site
2026-01-29
minor
Study Status, Oversight v4
Start date2025-12-01→2026-06-01
2025-08-14
minor
Study Status v3
Start date2025-06-15→2025-12-01
2025-05-22
minor
Study Status v2
Start date2025-04-01→2025-06-15
2025-03-21
minor
Study Status v1
Start date2025-03-01→2025-04-01
2025-02-13
minor
Original filing
1,015 trials monitored
See 115 trials at risk
The purpose of this study is to evaluate the impact of an extended oral Tranexamic Acid regimen on patient reported outcome scores, time to independent ambulation, postoperative range of motion, swelling, change in hemoglobin levels, 90-day complications, readmission and reoperation.
Trial Details
NCT Number NCT06832878
Lead Sponsor Mayo Clinic
Conditions Arthroplasty
Enrollment 101 participants
Start Date 2026-06-01
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-08-10